Pepto Bismol 262 mg/1
Bismuth subsalicylate · TABLET, CHEWABLE · The Procter & Gamble Manufacturing Company
Pepto Bismol is a tablet, chewable containing bismuth subsalicylate at 262 mg/1, taken oral. Manufactured by The Procter & Gamble Manufacturing Company.
Key Facts
- Brand Name
- Pepto Bismol
- Generic Name
- Bismuth subsalicylate
- NDC Code (Product)
84126-321- Manufacturer
- The Procter & Gamble Manufacturing Company
- Strength
- 262 mg/1
- Dosage Form
- TABLET, CHEWABLE
- Route
- ORAL
- Marketing Status
- Application #
- M008
- Drug Class
- Bismuth [EPC]
- Marketing Start
- 12/02/2024
Recall History
GOLD STAR DISTRIBUTION INC
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
Family Dollar Stores, Llc.
CGMP Deviations: product held outside appropriate storage temperature conditions.
Side Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Full Prescribing Information
Indications & Usage
Uses relieves travelers' diarrhea diarrhea upset stomach due to overindulgence in food and drink, including: heartburn indigestion nausea gas belching fullness
Dosage & Administration
Directions • swallow with water, do not chew • adults and children 12 years and over: 2 caplets (1 dose) every ½ hour or 4 caplets (2 doses) every hour as needed for diarrhea 2 caplets (1 dose) every ½ hour as needed for overindulgence (upset stomach, heartburn, indigestion, nausea) • do not exceed 8 doses (16 caplets) in 24 hours • use until diarrhea stops but not more than 2 days • children under 12 years: ask a doctor • drink plenty of clear fluids to help prevent dehydration caused by diarrhea
Warnings
Warnings Reye's syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's syndrome, a rare but serious illness. Allergy alert: Contains salicylate. Do not take if you are allergic to salicylates (including aspirin) taking other salicylate products Do not use if you have an ulcer a bleeding problem bloody or black stool Ask a doctor before use if you have fever mucus in the stool Ask a doctor or pharmacist before use if you are taking any drug for anticoagulation (thinning the blood) diabetes gout arthritis When using this product a temporary, but harmless, darkening of the stool and/or tongue may occur Stop use and ask a doctor if symptoms get worse or last more than 2 days ringing in the ears or loss of hearing occurs diarrhea lasts more than 2 days If pregnant or breast feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Frequently Asked Questions
What is Pepto Bismol used for?
Pepto Bismol contains Bismuth subsalicylate. It is a tablet, chewable taken oral. Consult your doctor for specific uses.
Is Pepto Bismol a controlled substance?
Pepto Bismol is not classified as a controlled substance by the DEA.
What is the generic name for Pepto Bismol?
The generic name for Pepto Bismol is Bismuth subsalicylate. There are 12 other brand versions of Bismuth subsalicylate.
What is the NDC code for Pepto Bismol 262 mg/1?
The NDC (National Drug Code) for Pepto Bismol 262 mg/1 is 84126-321, listed by The Procter & Gamble Manufacturing Company.
Other Bismuth Brands
See all →- AMAZON Regular Strength525 mg/30mL72288-706
- PEPT-ACHE262 mg/173598-1232
- Stomach Relief - Regular Strength525 mg/30mL76281-537
- Dye Free Regular Strength Stomach Relief525 mg/30mL79903-427
- Wonderbelly Multi-Symptom262 mg/182431-301
- Quality Choice Stomach Relief 528525 mg/15mL83324-021
- Revasol Peptic Relief525 mg/30mL84379-283
- Stomach Relief262 mg/185828-727
- Stomach Relief525 mg/30mL85828-791
- Rite Aid Regular Strngth Pink Bismuth525 mg/30mL11822-7016
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)